Alternate NDC Supply for DROSPIRENONE 4MG Tablets (Substitution Option)

The contract offers an opportunity to supply an equivalent formulation of DROSPIRENONE 4MG tablets under a non-catalog NDC, specifically requiring the adjustment of the order quantity to 1,000 units. Suppliers must provide a clear and documented justification for the substitution, demonstrating therapeutic equivalence and compliance with applicable standards to ensure patient safety and regulatory adherence. This solicitation is not tied to a pre-existing catalog item, placing the burden of proof on the respondent to validate the interchangeability of the proposed product. Issued under NAICS code 325412 by the Department of Veterans Affairs through its National Cmop Office, the contract is structured as a subcontract with a response deadline of June 30, 2026, at 10:00 PM. The place of performance is designated with a zip code of 29456, indicating the delivery location, though no specific city or state is provided. The opportunity is open for bid as of June 25, 2026, and interested parties must respond prior to the deadline with full documentation supporting the substitution request and adherence to the required volume.